PAPER Ishii K, Lippa C, Tomiyama T, Miyatake F, Ozawa K, Tamaoka A, Hasegawa T, Fraser PE, Shoji S, Nee LE, Pollen DA, St George-Hyslop PH, Ii K, Ohtake T, Kalaria RN, Rossor MN, Lantos PL, Cairns NJ, Farrer LA, Mori H
SEARCH RESULTS
340448 RESULTS
PAPER Gordon MN, King DL, Diamond DM, Jantzen PT, Boyett KV, Hope CE, Hatcher JM, DiCarlo G, Gottschall WP, Morgan D, Arendash GW
Correlation between cognitive deficits and Abeta deposits in transgenic APP+PS1 mice.
Neurobiol Aging. 2001 May-Jun;22(3):377-85. PubMed.PAPER Johnson RJ, Xiao G, Shanmugaratnam J, Fine RE
Calreticulin functions as a molecular chaperone for the beta-amyloid precursor protein.
Neurobiol Aging. 2001 May-Jun;22(3):387-95. PubMed.PAPER Shuvaev VV, Laffont I, Serot JM, Fujii J, Taniguchi N, Siest G
Increased protein glycation in cerebrospinal fluid of Alzheimer's disease.
Neurobiol Aging. 2001 May-Jun;22(3):397-402. PubMed.PAPER Nemes Z, Fésüs L, Egerházi A, Keszthelyi A, Degrell IM
N(epsilon)(gamma-glutamyl)lysine in cerebrospinal fluid marks Alzheimer type and vascular dementia.
Neurobiol Aging. 2001 May-Jun;22(3):403-6. PubMed.PAPER in't Veld BA, Ruitenberg A, Hofman A, Stricker BH, Breteler MM
Antihypertensive drugs and incidence of dementia: the Rotterdam Study.
Neurobiol Aging. 2001 May-Jun;22(3):407-12. PubMed.PAPER Scacchi R, Ruggeri M, Gambina G, Martini MC, Ferrari G, Corbo RM
Plasma alpha1-antichymotrypsin in Alzheimer's disease; relationships with APOE genotypes.
Neurobiol Aging. 2001 May-Jun;22(3):413-6. PubMed.PAPER Ishunina TA, Swaab DF
Increased expression of estrogen receptor alpha and beta in the nucleus basalis of Meynert in Alzheimer's disease.
Neurobiol Aging. 2001 May-Jun;22(3):417-26. PubMed.PAPER Stalder M, Deller T, Staufenbiel M, Jucker M
3D-Reconstruction of microglia and amyloid in APP23 transgenic mice: no evidence of intracellular amyloid.
Neurobiol Aging. 2001 May-Jun;22(3):427-34. PubMed.PAPER Szili-Török T, Kálmán J, Paprika D, Dibó G, Rózsa Z, Rudas L
Depressed baroreflex sensitivity in patients with Alzheimer's and Parkinson's disease.
Neurobiol Aging. 2001 May-Jun;22(3):435-8. PubMed.PAPER Golde TE, Younkin SG
Presenilins as therapeutic targets for the treatment of Alzheimer's disease.
Trends Mol Med. 2001 Jun;7(6):264-9. PubMed.PAPER Mann MB, Wu S, Rostamkhani M, Tourtellotte W, MacMurray J, Comings DE
Phenylethanolamine N-methyltransferase (PNMT) gene and early-onset Alzheimer disease.
Am J Med Genet. 2001 May 8;105(4):312-6. PubMed.PAPER Perry RT, Collins JS, Harrell LE, Acton RT, Go RC
Investigation of association of 13 polymorphisms in eight genes in southeastern African American Alzheimer disease patients as compared to age-matched controls.
Am J Med Genet. 2001 May 8;105(4):332-42. PubMed.PAPER Soriano S, Lu DC, Chandra S, Pietrzik CU, Koo EH
The amyloidogenic pathway of amyloid precursor protein (APP) is independent of its cleavage by caspases.
J Biol Chem. 2001 Aug 3;276(31):29045-50. Epub 2001 Jun 7 PubMed.PAPER Kirschenbaum F, Hsu SC, Cordell B, McCarthy JV
Glycogen synthase kinase-3beta regulates presenilin 1 C-terminal fragment levels.
J Biol Chem. 2001 Aug 17;276(33):30701-7. PubMed.Current Filters
No filters selected